Quick Answer
Xtant Medical Holdings, Inc. reported Total Revenue of $133.93 million for the year ending 2025.
- Xtant Medical Holdings, Inc. showed an increase of +14.2% in Total Revenue from 2024 to 2025.
- This data is from Xtant Medical Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $3.20 million | Q3 2010: $4.19 million | Q1 2011: $6.00 million | Q2 2011: $7.51 million | Q3 2011: $7.54 million | Q1 2012: $7.77 million | Q2 2017: $21.41 million | Q3 2017: $19.79 million | Q1 2018: $17.93 million | Q2 2018: $18.74 million | Q3 2018: $17.27 million | Q1 2019: $16.73 million | Q1 2019: $16.73 million | Q2 2019: $15.27 million | Q2 2019: $15.27 million | Q3 2019: $15.72 million | Q3 2019: $15.72 million | Q1 2020: $14.78 million | Q2 2020: $10.53 million | Q3 2020: $14.02 million | Q1 2021: $12.54 million | Q2 2021: $14.98 million | Q3 2021: $13.78 million | Q1 2022: $12.96 million | Q2 2022: $15.28 million | Q3 2022: $14.46 million | Q1 2023: $17.94 million | Q2 2023: $20.23 million | Q3 2023: $25.02 million | Q1 2024: $27.87 million | Q2 2024: $29.94 million | Q3 2024: $27.94 million | Q1 2025: $32.90 million | Q2 2025: $35.41 million | Q3 2025: $33.26 million.
- Over the full 12 years of available data (2010 to 2025), Xtant Medical Holdings, Inc.'s Total Revenue has grown by 768.7%.
- Historical annual values: Fiscal year 2025: $133.93 million | Fiscal year 2024: $117.27 million | Fiscal year 2023: $91.30 million | Fiscal year 2022: $57.97 million | Fiscal year 2021: $55.26 million | Fiscal year 2020: $53.34 million | Fiscal year 2019: $64.68 million | Fiscal year 2019: $64.68 million | Fiscal year 2018: $72.20 million | Fiscal year 2017: $82.61 million | Fiscal year 2011: $30.15 million | Fiscal year 2010: $15.42 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: